Literature DB >> 23434246

Innate immune activation after transfusion of stored red blood cells.

Matthew D Neal1, Jay S Raval, Darrell J Triulzi, Richard L Simmons.   

Abstract

The transfusion of red blood cells (RBCs), although necessary for treatment of anemia and blood loss, has also been linked to increased morbidity and mortality. RBCs stored for longer durations and transfused in larger volumes are often cited as contributory to adverse outcomes. The potential mechanisms underlying deleterious effects of RBC transfusion are just beginning to be elucidated. In this narrative review, we explore the hypothesis that prolonged RBC storage results in elaboration of substances which may function as danger associated molecular pattern molecules that activate the innate immune system with consequences unfavorable to healthy homeostasis. The nature of these chemical mediators and the biological responses to them offers insight into the mechanisms of these pathological responses. Three major areas of activation of the innate immune apparatus by stored RBCs have been tentatively identified: RBC hemolysis, recipient neutrophil priming, and reactive oxygen species production. The possible mechanisms by which each might perturb the innate immune response are reviewed in a search for potential novel pathways through which transfusion can lead to an altered inflammatory response.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23434246     DOI: 10.1016/j.tmrv.2013.01.001

Source DB:  PubMed          Journal:  Transfus Med Rev        ISSN: 0887-7963


  11 in total

1.  Hypoxanthine: a new paradigm to interpret the origin of transfusion toxicity.

Authors:  Emanuela Casali; Pamela Berni; Alberto Spisni; Roberto Baricchi; Thelma A Pertinhez
Journal:  Blood Transfus       Date:  2015-12-11       Impact factor: 3.443

2.  The impact of perioperative packed red blood cell transfusion on survival in epithelial ovarian cancer.

Authors:  Lindsay L Morgenstern Warner; Sean C Dowdy; Janice R Martin; Maureen A Lemens; Michaela E McGree; Amy L Weaver; Karl C Podratz; Jamie N Bakkum-Gamez
Journal:  Int J Gynecol Cancer       Date:  2013-11       Impact factor: 3.437

Review 3.  Red blood cell storage lesion: causes and potential clinical consequences.

Authors:  Tatsuro Yoshida; Michel Prudent; Angelo D'alessandro
Journal:  Blood Transfus       Date:  2019-01       Impact factor: 3.443

4.  Red blood cell transfusions increase fecal calprotectin levels in premature infants.

Authors:  T T B Ho; M W Groer; A A Luciano; A Schwartz; M Ji; B S Miladinovic; A Maheshwari; T L Ashmeade
Journal:  J Perinatol       Date:  2015-07-16       Impact factor: 2.521

Review 5.  Transfusion related morbidity in premature babies: Possible mechanisms and implications for practice.

Authors:  Keith James Collard
Journal:  World J Clin Pediatr       Date:  2014-08-08

6.  Aged Human Stored Red Blood Cell Supernatant Inhibits Macrophage Phagocytosis in an HMGB1 Dependent Manner After Trauma in a Murine Model.

Authors:  Kent R Zettel; Mitchell Dyer; Jay S Raval; Xubo Wu; John R Klune; Andres Gutierrez; Darrell J Triulzi; Timothy R Billiar; Matthew D Neal
Journal:  Shock       Date:  2017-02       Impact factor: 3.454

Review 7.  The Evolving Erythrocyte: Red Blood Cells as Modulators of Innate Immunity.

Authors:  H Luke Anderson; Igor E Brodsky; Nilam S Mangalmurti
Journal:  J Immunol       Date:  2018-09-01       Impact factor: 5.422

Review 8.  Mechanisms of red blood cell transfusion-related immunomodulation.

Authors:  Kenneth E Remy; Mark W Hall; Jill Cholette; Nicole P Juffermans; Kathleen Nicol; Allan Doctor; Neil Blumberg; Philip C Spinella; Philip J Norris; Mary K Dahmer; Jennifer A Muszynski
Journal:  Transfusion       Date:  2018-01-30       Impact factor: 3.157

9.  Effects of the prospective payment system on anemia management in maintenance dialysis patients: implications for cost and site of care.

Authors:  James B Wetmore; Spiros Tzivelekis; Allan J Collins; Craig A Solid
Journal:  BMC Nephrol       Date:  2016-05-26       Impact factor: 2.388

10.  ABO Mismatch in Allogeneic Hematopoietic Stem Cell Transplant: Effect on Short- and Long-term Outcomes.

Authors:  Caterina Giovanna Valentini; Elisabetta Metafuni; Lorenzo Gallo; Sabrina Giammarco; Nicoletta Orlando; Maria Bianchi; Simona Sica; Andrea Bacigalupo; Patrizia Chiusolo; Luciana Teofili
Journal:  Transplant Direct       Date:  2021-07-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.